Puma Biotechnology, Inc. (PBYI)
7.60
-0.18
(-2.31%)
USD |
NASDAQ |
Apr 13, 14:16
Puma Biotechnology Price : 7.60 for April 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Rigel Pharmaceuticals, Inc. | 29.67 |
| Agios Pharmaceuticals, Inc. | 33.01 |
| Editas Medicine, Inc. | 3.19 |
| Trevi Therapeutics, Inc. | 13.07 |
| Phathom Pharmaceuticals, Inc. | 12.84 |
Price Related Metrics
| PE Ratio | 12.44 |
| PS Ratio | 1.685 |
| PEG Ratio | 126.54 |
| Price to Book Value | 2.967 |
| Price to Free Cash Flow | 9.220 |
| Earnings Yield | 8.04% |
| Market Cap | 386.66M |
| PEGY Ratio | 126.54 |
| Operating PE Ratio | 10.32 |
| Normalized PE Ratio | 12.44 |